X

LATEST

Ocean Biomedical focuses its malaria program to address chronic malaria crisis in sub-Saharan Africa

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it is focusing its multi-pronged malaria program to address the…

We see public listing as the next logical step in our growth as an organization: CEO of Aeries

Aeries Technology is a global services company providing technology, business process management and transformation services to some of the leading global…

Superlatus names Dr. Eugenio Bortone COO; interim CEO Tim Alford to become CCO

Superlatus, Inc., a holding company of food products and distribution capabilities, on Tuesday, announced new appointments to its management team.…

Ocean Biomedical (OCEA) joins the Russell 2000 Index

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market…

Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment

Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a…

Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform

Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be…

Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice…

Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock…

Initial response to single-serve pour-over product is the driver behind NuZee’s business: CEO

NuZee, Inc. (NASDAQ: NUZE) is a leading coffee technology and co-packing company that provides end-to-end sustainable solutions for clients ranging…

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said…